-+ 0.00%
-+ 0.00%
-+ 0.00%

Bruker showcases expanding infection diagnostics portfolio at ASM Microbe 2026

PUBT·06/04/2026 11:02:08
Listen to the news
Bruker showcases expanding infection diagnostics portfolio at ASM Microbe 2026
  • Bruker attended ASM Microbe 2026 to showcase its expanding Microbiology & Infection Diagnostics portfolio.
  • It highlighted expanded FDA-cleared MALDI Biotyper CA capabilities, outlined a rapid sepsis AST workflow in development, cited 140 new U.S. placements in 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260604057503) on June 04, 2026, and is solely responsible for the information contained therein.